205 results Stibbe advises Syntus and its shareholder Keolis Stibbe advised Syntus and its shareholder Keolis in connection with the procurement, acquisition, financing and maintenance of trains for the Zwolle – Enschede and Zwolle – Kampen concessions. Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here. Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b Stibbe advises the Ministry of Infrastructure and Environment Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises EPZ Stibbe advises SITA Stibbe advises Sodexo Stibbe advises Immo Coronmeusse Stibbe advised Immo Coronmeusse on the public procurement of redevelopment and reconstruction works of the Coronmeuse site in Liège. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises Sofico Stibbe advised SOFICO (Société de Financement Complémentaire des infrastructures), a public investment company created by the Walloon Region, on its plans to install LED lights on the 2,300km road network. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises Brussels Airport Company Stibbe advised the Brussels Airport Company on the real estate aspects and bidding procedure regarding the redevelopment of the Gateway Building at Brussels Airport. Stibbe advises on the IPO of Tornier Pagination Previous page Page 9 Current page 10 Page 11 Page 12 Next page
Stibbe advises Syntus and its shareholder Keolis Stibbe advised Syntus and its shareholder Keolis in connection with the procurement, acquisition, financing and maintenance of trains for the Zwolle – Enschede and Zwolle – Kampen concessions.
Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here.
Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Immo Coronmeusse Stibbe advised Immo Coronmeusse on the public procurement of redevelopment and reconstruction works of the Coronmeuse site in Liège.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises Sofico Stibbe advised SOFICO (Société de Financement Complémentaire des infrastructures), a public investment company created by the Walloon Region, on its plans to install LED lights on the 2,300km road network.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Brussels Airport Company Stibbe advised the Brussels Airport Company on the real estate aspects and bidding procedure regarding the redevelopment of the Gateway Building at Brussels Airport.